SPAIN'S PHARMACISTS IN LICENSE WRANGLE

19 June 1994

Around 100 pharmacists in Granada, Spain, have joined together to fight for the right to open pharmacies in Spain without restrictions. Currently there are regulations which fix the distance between pharmacies in Spain and the newly-formed association in Granada, Alaofe, wants to see this restriction removed, along with the restriction which covers the number of inhabitants in the area.

Fernando Ordonez, president of Spain's tribunal for the defense of competition, has said that these restrictions, the fact that only a qualified pharmacist can own a pharmacy, and a pharmacy's exclusivity over sale of nonprescription medicines are serious infringements of competition within the pharmaceutical sector.

All other European countries, with the exception of the UK, have some form of restrictions controlling the opening up of pharmacies.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight